Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
Daria Camilli, Education and Communication Manager at EHC – European Haemophilia Consortium, shared EHC – European Haemophilia Consortiumon post on LinkedIn:
“I am so proud to bring the EHC Health Economics Course 2026 to life for its 4th consecutive year!
Receiving 100percent positive feedback across previous editions speaks volumes about the impact of this initiative.
Advocacy builds on the foundation of knowledge. Knowing your treatment is only half the battle you also need to understand how it is assessed to effectively and confidently advocate for your treatment of choice.
A huge thank you to our speakers from Prime HCD and Brenda Cecilia Padilla Rodriguez for the seamless teamwork. Special thanks to Maria Elisa Mancuso for sharing her deep expertise on the bleeding disorder treatment landscape with our participants.”
EHC (European Haemophilia Consortium) shared a post on LinkedIn:
“The EHC Health Economics Course 2026 starts today!
Registered participants can access the EHC Health Economics Course 2026 and begin their learning journey.
Over four modules, you’ll explore health economics, health technology assessment (HTA), cost effectiveness analysis, and payment models all through the lens of bleeding disorders.
The course runs until 23 October 2026, so log in, get started, and make the most of every module.
A tip from past attendees: dedicate time every day to learning to achieve the best results!
We can’t wait to see what this year’s participants will contribute to the bleeding disorders community!”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias
-
Sep 17, 2026, 14:51Konstantin Yenkoyan: Emicizumab and the Power of Translational Science